EMPAGLYN M 12.5/1000MG

Empaglyn M 12.5/1000 mg Extended Release Tablet is a medication designed to assist in managing blood glucose levels. It is primarily utilized in conjunction with dietary adjustments and physical activity to enhance glycemic control in individuals diagnosed with type 2 diabetes mellitus. The formulation aids in optimizing insulin utilization, thus facilitating a reduction in blood sugar levels. It is recommended that this medication be taken with food at any time throughout the day; however, consistency in timing is encouraged for maximum effectiveness. The prescribed dosage will be determined by a healthcare professional. It is critical to consult a physician before discontinuing use, as abrupt cessation could lead to a rise in blood sugar levels, heightening the risk of severe complications like renal impairment and vision loss. This medication serves as a component of a comprehensive treatment strategy that includes nutritional management, regular exercise, and weight management as prescribed by your healthcare provider. Common adverse reactions associated with this medication may encompass alterations in taste, feelings of nausea, vomiting, diarrhea, joint discomfort, urinary tract infections, and yeast infections. In order to mitigate the risk of dehydration, it is advised to maintain adequate fluid intake while on this medication. Additionally, some users may experience fungal infections in the genital region, for which good hygiene practices are recommended. Prior to starting this medication, it is essential to inform your healthcare provider of any existing kidney or liver conditions, urinary tract infections, or if you are taking diuretics. Pregnant or nursing individuals should also seek medical advice before initiating treatment. Regular monitoring of blood glucose levels is advised during the usage of this medication.